Malaysia Health Ministry Defends Vape Regulations Over Total Ban

Nov.15.2024
Malaysia Health Ministry Defends Vape Regulations Over Total Ban
Malaysian health minister defends government's e-cigarette regulations over total ban, emphasizing new laws will evolve with emerging evidence.

The Malaysian government is defending its decision to regulate vape under the Control of Smoking Products for Public Health Act 2024 rather than imposing an outright ban, according to NST on November 14.

 

"If we had banned it (altogether), it would have been easier. But we missed that opportunity," Health Minister Datuk Seri Dr Dzulkefly Ahmad said after the launch of the 'Prevention and Control of Non-communicable Diseases' in Malaysia: The Case for Investment' report at Parliament's Banquet Hall here today.

 

"This piece of legislation is very comprehensive, covering everything from registration to the end of the supply chain."

 

The Control of Smoking Products for Public Health Act 2024, came into effect on October 1st, aiming to prohibit the sale and purchase of tobacco products, smoking materials, and alternatives to minors, including e-cigarettes and other electronic smoking devices.

 

In response to concerns about potential health risks of e-cigarettes, the minister assured that as new evidence emerges, laws will continue to evolve.

 

"If new evidence arises, we will revisit the issue. The law is dynamic, never static," Dr Dzulkefly said.

 

During an earlier session of the House of Commons, Zuckferry pointed out that the government had to spend over $30,000 on treating patients with lung injuries caused by the use of e-cigarettes or related products. If no control measures are taken, the estimated cost of treatment is projected to increase to $82.24 million annually by 2030.

 

Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives